Dr. Sandip Patel is a highly skilled medical oncologist with a specialization in phase 1 immunotherapy and thoracic oncology trials. He is deeply involved in researching predictive biomarkers for immunotherapy responses and developing personalized cancer immunotherapy solutions. Dr. Patel holds key leadership positions such as Co-Leader of the Experimental Therapeutics Phase 1 Program, Deputy Director at the San Diego Center for Precision Immunotherapy, and Assistant Director of the Clinical Trials Office. He is actively engaged as a member of the Thoracic Oncology and Cancer Immunotherapy Programs.